SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-021828
Filing Date
2016-08-01
Accepted
2016-08-01 08:31:13
Documents
53
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q thld-10q_20160630.htm 10-Q 1530634
2 EX-31.1 thld-ex311_9.htm EX-31.1 15562
3 EX-31.2 thld-ex312_7.htm EX-31.2 15586
4 EX-32.1 thld-ex321_8.htm EX-32.1 6187
5 EX-32.2 thld-ex322_11.htm EX-32.2 6267
  Complete submission text file 0001564590-16-021828.txt   5884477

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT thld-20160630.xml EX-101.INS 1518174
7 XBRL TAXONOMY EXTENSION SCHEMA thld-20160630.xsd EX-101.SCH 29071
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thld-20160630_cal.xml EX-101.CAL 35075
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thld-20160630_def.xml EX-101.DEF 105889
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE thld-20160630_lab.xml EX-101.LAB 260144
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thld-20160630_pre.xml EX-101.PRE 217078
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32979 | Film No.: 161795890
SIC: 2834 Pharmaceutical Preparations